Dr. Tess Lawrie is a world-class researcher and consultant to the World Health Organisation. Her biggest clients happen to be those who are involved in the suppression of repurposed drugs. She has decided to speak out in protest against the current medical establishment at considerable personal risk.
She co-founded the BiRD Group; an international consortium of experts dedicated to the transparent and accurate scientific research of Ivermectin, with particular emphasis on the treatment and prevention of Covid-19.
The First International Ivermectin for Covid Conference
The first ever conference focusing on the use of ivermectin (IVM) as a prophylaxis and treatment for covid-19.
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic.
See a complete discussion from the world’s leading Doctors and Researchers
https://bird-group.org/conference-post-event/
Nurse Nichole-On Ivermectin
Dr. Allan Landrito’s INFO-VIDEO on Ivermectin
Dr. Allan Landrito’s INFO-VIDEO on Ivermectin
“Can ivermectin really do all you’ve said it can do—prevent and treat all phases of COVID-19 disease? It seems too good to be true – again.”
The answer to this question relies on the fact that ivermectin, since its development 40 years ago, has already demonstrated its ability to make historic impacts on global health, given it led to the eradication of a “pandemic” of parasitic diseases across multiple continents. These impacts are what awarded the discoverers of ivermectin the 2015 Nobel prize
I-Protect : The ivermectin protocol
What is the protocol in using Ivermectin for prophylaxis and early treatment?
On Viruses and Ivermectin
Fact: The Zika virus is a single-stranded RNA virus.
Fact: The dengue virus is a single-stranded RNA virus.
Fact: Yellow river is a single-stranded RNA virus.
Fact: Chikungunya is a single-stranded RNA virus.
Fact: Sindbis is a single-stranded RNA virus.
Fact: Semliki forest is a single-stranded RNA virus.
Fact: Avian influenza A is a single-stranded RNA virus.
Fact: Ivermectin is proven to be effective against Zika.
Fact: Ivermectin is proven to be effective against Dengue.
Fact: Ivermectin is proven to be effective against Yellow River.
Fact: Ivermectin is proven to be effective against Sindbis.
Fact: Ivermectin is proven to be effective against Semliki Forest.
Fact: Ivermectin is proven to be effective against Avian influenza A.
Fact: Human grade ivermectin is effective against all these as it is able to inhibit the replication process, which they all share.
Fact: SARS-CoViD-2 is a single stranded RNA virus.
Fact: SARS-CoViD-2 shares the same replication process.
October 2020
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
Abstract Background/aim: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One drug that has attracted interest is the antiparasitic compound ivermectin, a macrocyclic lactone derived from the bacterium Streptomyces avermitilis. We carried out a docking study to determine if ivermectin might be able to attach to [...]
May 2020
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
Abstract Infection by RNA viruses such as human immunodeficiency virus (HIV)-1, influenza, and dengue virus (DENV) represent a major burden for human health worldwide. Although RNA viruses replicate in the infected host cell cytoplasm, the nucleus is central to key stages of the infectious cycle of HIV-1 and influenza, and an important target of DENV [...]
August 2014
Ivermectin: panacea for resource-poor communities?
Abstract The 2014 Gairdner Global Health Award was conferred for discovery of the unique microorganism that is the sole source of the endectocidal avermectins, and the Public sector/Private sector Partnership that developed innovative biopharmaceuticals with immeasurably beneficial impact on public health worldwide. Ivermectin is already labelled a 'wonder drug', essential for campaigns to eliminate two [...]
September 2013
Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
Abstract Infection by one of the 4 distinct serotypes of dengue virus (DENV) threatens >40% of the world's population, with no efficacious vaccine or antiviral agent currently available. DENV replication through the virus-encoded nonstructural protein (NS) 5 protein occurs in the infected cell cytoplasm, but NS5 from DENV2 has thus far been shown to localize [...]
May 2012
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Abstract The movement of proteins between the cytoplasm and nucleus mediated by the importin superfamily of proteins is essential to many cellular processes, including differentiation and development, and is critical to disease states such as viral disease and oncogenesis. We recently developed a high-throughput screen to identify specific and general inhibitors of protein nuclear import, [...]
November 0202
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
Abstract Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and safety of ivermectin among adult SARS-CoV-2 patients. The trial included 72 hospitalized patients in Dhaka, Bangladesh, [...]